sb 239063 has been researched along with Cardiac Failure in 3 studies
SB 239063: structure in first source
SB-239063 : A member of the class of imidazoles carrying 4-hydroxycyclohexyl, 4-fluorophenyl and 2-methoxypyrimidin-4-yl substituents at positions 1, 4 and 5 respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Widder, J | 1 |
| Behr, T | 1 |
| Fraccarollo, D | 1 |
| Hu, K | 1 |
| Galuppo, P | 1 |
| Tas, P | 1 |
| Angermann, CE | 1 |
| Ertl, G | 1 |
| Bauersachs, J | 1 |
| de Boer, RA | 1 |
| Pokharel, S | 1 |
| Flesch, M | 1 |
| van Kampen, DA | 1 |
| Suurmeijer, AJ | 1 |
| Boomsma, F | 1 |
| van Gilst, WH | 1 |
| van Veldhuisen, DJ | 1 |
| Pinto, YM | 1 |
| Feuerstein, GZ | 1 |
3 other studies available for sb 239063 and Cardiac Failure
| Article | Year |
|---|---|
Vascular endothelial dysfunction and superoxide anion production in heart failure are p38 MAP kinase-dependent.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Endothelium, Vascular; Heart Failu | 2004 |
Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Atr | 2004 |
Apoptosis--new opportunities for novel therapeutics for heart diseases.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Apoptosis; Carbazoles; Carvedilol; DN | 2001 |